Phase III Randomized Study of SYNSORB Pk in Children With E. Coli-Associated Hemolytic Uremic Syndrome
Stopped Lack of efficacy at review by DSMB using pre-specified monitoring criteria
Conditions
- Hemolytic Uremic Syndrome
Interventions
- DRUG: SYNSORB Pk
- DRUG: Placebo
Sponsor
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Collaborators